A double-blind, randomized study comparing itraconazole pulse therapy with continuous for the treatment of toe-nail onychomycosis

British Journal of Dermatology

Volumn 136, Issue 2, 1997, Pages 230-234

  Havu, V ^a   Brandt, H ^b   Heikkila H ^c   Hollmen, A ^d   Oksman, R ^a   Rantanen, T ^e   Saari, S ^a   Stubb, S ^c   Turjanmaa, K ^f   Piepponen, T ^g  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b Helsingin Laakarikeskus   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d Vuorikadun Laakariasema   (Finland)

^e Savonlinna Central Hospital   (Finland)

^f Koskiklinikka   (Finland)

^g Department of Clinical Research   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATITIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG SAFETY; FEMALE; FLATULENCE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; IMPOTENCE; MAJOR CLINICAL STUDY; MALE; NAUSEA; ONYCHOMYCOSIS; ORAL DRUG ADMINISTRATION; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOE;

EID: 8044221527     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb14902.x     Document Type: Article

References (20)

1. Scher RK. Onychomycosis is more than a cosmetic problem. Br J Dermatol 1994; 130 (Suppl. 43): 15-16.
2. Heikkilä H, Stubb S. The prevalence of onychomycosis in Finland. Br J Dermatol 1995; 133: 699-703.
3. Ramesh V, Reddy BSN, Singh R. Onychomycosis. Int J Dermatol 1983; 22: 148-52.
4. André J, Achten G. Onychomycosis. Int J Dermatol 1987; 26: 481-90.
5. Sharpe M, Mayou R, Seagroatt V et al. Why do doctors find some patients difficult to help? Q J Med 1994; 87: 187-93.
6. Davies RR, Everall JD, Hamilton E. Mycological and clinical evaluation of griseofulvin for chronic onychomycosis. Br Med J 1967: 464-8.
7. van Cutsem J, van Gerven F, Janssen PAJ. Activity of orally, topically and parentally administered itraconazole in the treatment of superficial and deep mycoses: animal models. Rev Infect Dis 1987; 9 (Suppl. 1): 15-32.
8. van Cutsem J. The in vitro antifungal spectrum of itraconazole. Myroses 1989; 32 (Suppl. 1): 7-13.
9. Roseeuw D, Willemsen M, Kint R et al. Itraconazole in the treatment of superficial mycoses - a double blind study vs. placebo. Clin Exp Dermatol 1990; 15: 101-4.
10. Piepponen T, Blomqvist K, Brandt H et al. Efficacy and safety of itraconazole in the long-term treatment of onychomycosis. J Antimicrob Chemother 1992; 29: 195-205.
11. Arenas R, Fernandez G, Dominquez L. Onychomycosis treated with itraconazole or griseofulvin alone with and without a topical antimycolic or keratolytic agent. Int J Dermatol 1991; 30: 586-9.
12. Walsoe I, Stangerup M, Svejgaard E. Itraconazole in onychomycosis. Open and double-blind studies. Acta Derm Venereol (Stockh) 1990; 70: 137-40.
13. De Beule K, Lubin G, Cauwenbergh G. Safety aspects of itraconazole in vaginal candidosis, dermatomycosis and onychomycosis. A review. Curr Ther Res 1991; 272-310.
14. Willemsen R, De Doncker P, Willems J et al. Post-treatment itraconazole levels in the nail. New implications for treatment in onychomycosis. J Am Acad Dermatol 1992; 26: 731-5.
15. Heykants J, van Peer A, van de Velde V et al. The clinical pharmacokinetics of itraconazole: an overview. Mycoses 1989; 32 (Suppl. 1): 67-87.
16. Cauwenbergh G, Degreef H, Heykants J et al. Pharmacokinetic profile of orally administered itraconazole in human skin. J Am Acad Dermatol 1988; 18: 263-8.
17. Matthieu L, De Doncker P, Cauwenbergh G et al. Itraconazole penetrates the nail via the nail matrix and nail bed: an investigation in onychomycosis. Clin Exp Dermatol 1991; 16: 374-6.
18. Dubois D. Cost-effectiveness of antifungal pulse therapy. Proceedings of the 2nd International Symposium on Onychomycosis. 28-29 September. 1995. Florence, Italy, 38-40.
19. De Doncker P, Decroix J, Piérard GE et al. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole. Arch Dermatol 1996; 132: 34-41.
20. Blackwelder W. 'Proving the null hypothesis' in clinical trials. Controlled Clin Trials 1982; 3: 345-53.